SCHEMBL29820511

SCHEMBL29820511

CC(C)c1ccc(C(NC(=O)C2CC(F)CN2C(=O)Cc2n[nH]c(=O)n2C)c2ccccc2)nc1

nearest known ligand 0.34

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ CFD P00746 15/20 0.34
▸ PSMB9 P28065 1/20 0.33
▸ DRD2 P14416 2/20 0.33
▸ XIAP P98170 1/20 0.32
▸ MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24666304 1.00 CFD (0.34) CFDPSMB9DRD2XIAPMAPK1
SCHEMBL24665687 0.89 CFD (0.36) CFDPSMB9DRD2
SCHEMBL29230886 0.89 CFD (0.36) CFDPSMB9DRD2
SCHEMBL29820441 0.87 PSMB9 (0.34) CFDPSMB9DRD2
SCHEMBL24664621 0.87 PSMB9 (0.34) CFDPSMB9DRD2
SCHEMBL24666302 0.87 CFD (0.35) CFDPSMB9XIAP
SCHEMBL29820129 0.87 CFD (0.35) CFDPSMB9XIAP
SCHEMBL24666299 0.87 CFD (0.34) CFDPSMB9XIAP
SCHEMBL29231430 0.87 CFD (0.34) CFDPSMB9XIAP
SCHEMBL26833067 0.86 CFD (0.40) CFDDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4308095-A1 INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOF Maze Therapeutics, Inc. (US) 2024-01-24 — — EP disclosed
WO-2022198196-A1 INHIBITORS OF GLYCOGEN SYNTHASE 1 (GYS1) AND METHODS OF USE THEREOF MAZE THERAPEUTICS, INC. (US) 2022-09-22 — — WO disclosed
Send feedback